Stem-cell-like T cells have a specific entry gate to the tumor

Tumor-infiltrated T cells with stem-cell-like properties are important for determining the immunotherapy response. In this issue of Cancer Cell, Asrir and colleagues show that their entry requires specialized tumor-associated endothelial cells that resemble immature and inflamed lymph node vessels and that immunotherapy enhances the recruitment capacity of these endothelial cells.

Automated summary

Tumor-infiltrated T cells with stem-cell-like properties play a crucial role in determining the response to immunotherapy. The latest research suggests that their entry into tumor tissue relies on specialized tumor-associated endothelial cells that resemble immature and inflamed lymph node vessels. Furthermore, immunotherapy has been found to enhance the recruitment capacity of these endothelial cells.